| Michelle Renee Birdsell, MD | |
|
4500 College Blvd, Suite 304, Overland Park, KS 66211-1799 | |
| (913) 338-0400 | |
| (913) 338-0428 |
| Full Name | Michelle Renee Birdsell |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 4500 College Blvd, Overland Park, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386838605 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 2007001662 (Missouri) | Primary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | T-01448 (Kansas) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Renee Birdsell, MD 4770 N Belleview Ave, Suite 207, Kansas City, MO 64116-2188 Ph: (913) 338-0400 | Michelle Renee Birdsell, MD 4500 College Blvd, Suite 304, Overland Park, KS 66211-1799 Ph: (913) 338-0400 |
News Archive
In a new study, published on the pre-print server medRxiv, an international team of researchers found that a one-dose policy may increase the potential for antigenic evolution. The study revealed that focusing on one dose may decrease infections in the short term, but longer-term outcomes rely on this immune strength.
Amgen and Merck, known as MSD outside the U.S. and Canada, today announced an expanded collaboration to evaluate the efficacy and safety of talimogene laherparepvec, Amgen's investigational oncolytic immunotherapy, in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in a Phase 1, open-label trial of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).
Synopsys' Simpleware ScanIP Medical is now available for 3D medical printing after receiving FDA 510(k) clearance in this area.
Two studies in mice from Baylor College of Medicine, Texas, reveal new insights into neurons that mediate symptoms typical of the postnatal neurological disorder Rett syndrome.
› Verified 2 days ago
Anne S. Clark, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10500 Barkley St Ste 220, Overland Park, KS 66212 Phone: 913-738-9235 Fax: 913-738-9285 | |
Stacy Dawn Younger, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12140 Nall Ave, Suite 230, Overland Park, KS 66209 Phone: 913-661-9434 Fax: 913-661-4688 | |
Dr. Beverley Faye James, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9101 W 73rd St Apt 206, Overland Park, KS 66204 Phone: 913-262-6161 | |
Muhammad Mahdi Nashatizadeh, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 10550 Quivira Rd, Suite 530, Overland Park, KS 66215 Phone: 913-599-3828 Fax: 913-599-3451 | |
Ian Leslie Belson, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12140 Nall, Suite 230, Overland Park, KS 66209 Phone: 913-661-9434 Fax: 913-661-4688 | |
Dr. Bernard Mark Abrams, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 5520 College Boulevard, Suite 320, Overland Park, KS 66211 Phone: 816-322-4834 Fax: 816-322-2005 | |
Dr. Joan Mollman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5347 W 100th Ter, Overland Park, KS 66207 Phone: 610-864-8338 |